Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dopamine D3 Receptor Ligand Suppresses the Expression of Levodopa-Induced Dyskinesia in Nonhuman Primate Model of Parkinson’s Disease

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.10.455884Source: DataRank Database

Dopamine D3 Receptor Ligand Suppresses the Expression of Levodopa-Induced Dyskinesia in Nonhuman Primate Model of Parkinson’s Disease is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (34)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Elyas S. Daadi,Jeffrey Kim,Etienne W. Daadi ORCID,Peng‐Jen Chen ORCID,Gourav Roy-Choudhury

Live enrichment

PubMed:26207759 OpenAlex:https://openalex.org/W3191900546

Fundação para a Ciência e a Tecnologia, I.P.

Grant: PTDC/CCI-BIO/29266/2017

Deep Drug Discovery and Deployment

National Institutes of Health

Grant: 3P51OD011133-22S2

Nonhuman Primate model of age-related cognitive decline and dementias

National Institutes of Health

Grant: 1R56AG059284-01

Impact of Physical Activity on Striatal Reinnervation in a Nonhuman Primate Model of Parkinson's Disease

greenLicense: CC BY

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/08/11/2021.08.10.455884.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.08.10.455884

repositoryhttps://doi.org/10.1101/2021.08.10.455884

https://doi.org/10.1016/j.expneurol.2021.113920

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsAutism Spectrum Disorder ResearchNeurotransmitter Receptor Influence on Behavior03 medical and health sciences0302 clinical medicine

Keywords

DyskinesiaLevodopaParkinson's diseaseDopamine receptor D3DopamineMedicineDiseasePharmacologyAgonistDopamine receptorNeuroscienceOncologyPsychologyInternal medicineReceptorPrimatesDyskinesia, Drug-InducedQuinpiroleDopamine AgentsReceptors, Dopamine D3CallithrixLigandsProtein Structure, SecondaryAntiparkinson AgentsHEK293 CellsParkinsonian DisordersDopamine AgonistsAnimalsHumans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being